Tamoxifen associated to the conservative CKD treatment promoted additional antifibrotic effects on experimental hypertensive nephrosclerosis
Abstract CKD progression depends on the activation of an intricate set of hemodynamic and inflammatory mechanisms, promoting renal leukocyte infiltration, inflammation and fibrosis, leading to renal function loss. There are currently no specific drugs to detain renal fibrogenesis, which is a common...
Main Authors: | Camilla Fanelli, Ana L. R. Francini, Giovanna A. Celestrino, Flávio Teles, Ana P. Barbosa, Paloma Noda, Leandro R. Iannuzzi, Cristiane R. Guzzo, Felipe M. Ornellas, Irene L. Noronha |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2023-08-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-023-39299-9 |
Similar Items
-
Influence of variability in the cyclooxygenase pathway on cardiovascular outcomes of nephrosclerosis patients
by: Luz M. González, et al.
Published: (2023-01-01) -
EFFECTS OF MEVALONATE PATHWAY MODULATORS UPON REACTIVITY OF MACROPHAGES IN E XPERIMENTAL NEPHROSCLEROSIS
by: Ya. Sh. Schwarz, et al.
Published: (2014-07-01) -
Tag-SNPs in Phospholipase-Related Genes Modify the Susceptibility to Nephrosclerosis and its Associated Cardiovascular Risk
by: Luz M. González, et al.
Published: (2022-05-01) -
Genetic Variants in PGE2 Receptors Modulate the Risk of Nephrosclerosis and Clinical Outcomes in These Patients
by: Luz María González, et al.
Published: (2021-08-01) -
Role of antifibrotics in post-COVID fibrosis: Yes or no?
by: R Narasimhan
Published: (2021-01-01)